Reversible language regression as an adverse effect of topiramate treatment in children

被引：25

作者：

Gross-Tsur, V ^{[1
]}

Shalev, RS ^{[1
]}

机构：

[1] Shaare Zedek Med Ctr, Neuropediat Unit, IL-91031 Jerusalem, Israel

来源：

NEUROLOGY | 2004年 / 62卷 / 02期

关键词：

D O I：

10.1212/01.WNL.0000103285.85821.B3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Profound language regression developed in three children with epilepsy 4 to 28 weeks after beginning topiramate (TPM). TPM was administered as an adjunctive antiepileptic drug at doses of 2.5 to 6.0 mg/kg/day. Language functions recovered while TPM was being reduced in dose or stopped.

引用

页码：299 / 300

页数：2

共 10 条

[1] A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children [J].

Elterman, RD ;

Glauser, TA ;

Wyllie, E ;

Reife, R ;

Wu, SC ;

Pledger, G .

NEUROLOGY, 1999, 52 (07) :1338-1344

[2] A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy [J].

Gilliam, FG ;

Veloso, F ;

Bomhof, MAM ;

Gazda, SK ;

Biton, V ;

Ter Bruggen, JP ;

Neto, W ;

Bailey, C ;

Pledger, G ;

Wu, SC .

NEUROLOGY, 2003, 60 (02) :196-202

[3] An open-label trial of bromocriptine in nonfluent aphasia: A qualitative analysis of word storage and retrieval [J].

Gold, M ;

VanDam, D ;

Silliman, ER .

BRAIN AND LANGUAGE, 2000, 74 (02) :141-156

[4] Oral topiramate for treatment of alcohol dependence: a randomised controlled trial [J].

Johnson, BA ;

Ait-Daoud, N ;

Bowden, CL ;

DiClemente, CC ;

Roache, JD ;

Lawson, K ;

Javors, MA ;

Ma, JZ .

LANCET, 2003, 361 (9370) :1677-1685

[5] Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy [J].

Langtry, HD ;

Gillis, JC ;

Davis, R .

DRUGS, 1997, 54 (05) :752-773

[6] The effects of adjunctive topiramate on cognitive function in patients with epilepsy [J].

Lee, S ;

Sziklas, V ;

Andermann, F ;

Farnham, S ;

Risse, G ;

Gustafson, M ;

Gates, J ;

Penovich, P ;

Al-Asmi, A ;

Dubeau, F ;

Jones-Gotman, M .

EPILEPSIA, 2003, 44 (03) :339-347

[7] Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy [J].

Lhatoo, SD ;

Wong, ICK ;

Sander, JWAS .

EPILEPSIA, 2000, 41 (03) :338-341

[8] Topiramate and word-finding difficulties in patients with epilepsy [J].

Mula, M ;

Trimble, MR ;

Thompson, P ;

Sander, JWAS .

NEUROLOGY, 2003, 60 (07) :1104-1107

[9] Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy [J].

Privitera, MD ;

Brodie, MJ ;

Mattson, RH ;

Chadwick, DW ;

Neto, W ;

Wang, S .

ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 (03) :165-175

[10]

Shinnar S, 2001, PEDIATR NEUROL, V24, P183, DOI 10.1016/S0887-8994(00)00266-6

← 1 →